| 6.46 Data as of 3:59pm ET |  -0.22 / -3.29%Today’s Change | 2.27 Today|||52-Week Range 7.30 | +51.64% Year-to-Date |
| Previous close | 6.68 |
| Today’s open | 6.65 |
| Day’s range | 6.44 - 6.93 |
| Volume | 446,886 |
| Average volume (3 months) | 304,068 |
| Market cap | $248.7M |
| Dividend yield | -- |
| Earnings growth (last year) | -30.17% |
| Earnings growth (this year) | +34.66% |
| Earnings growth (next 5 years) | +79.70% |
| Revenue growth (last year) | +123.32% |
| P/E ratio | NM |
| Price/Sales | 39.37 |
| Price/Book | 7.31 |
| Today’s change | Today’s % change | |
|---|---|---|
| ANACAnacor Pharmaceutica... | -0.44 | -7.22% |
| RGLSRegulus Therapeutics... | -0.10 | -1.41% |
| CRTXCornerstone Therapeu... | -0.05 | -0.56% |
| SCLNSciClone Pharmaceuti... | +0.02 | +0.41% |
| Next reporting date | August 15, 2013 |
| EPS forecast (this quarter) | -$0.25 |
| Annual revenue (last year) | $2.4M |
| Annual profit (last year) | -$33.4M |
| Net profit margin | -1,393.61% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director Richard A. King, MBA |
Vice President- Business Operations Carter J. King, MBA |
Corporate headquarters Redwood City, California |
.
